oral, covalent, allosteric WRN helicase inhibitor Ph. I for MSI and/or dMMR advanced solid tumors chemoproteomics screening technology AACR Annual Meeting 2024 New Drugs on the Horizon Vividion Therapeutics, San Diego, CA / Roche, Basel, CH